{{Rsnum
|rsid=2912602
|Chromosome=15
|position=26474092
|Orientation=minus
|GMAF=0.1377
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 85.0 | 15.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 17.0 | 56.5 | 26.5
| ASW | 49.1 | 40.4 | 10.5
| CHB | 100.0 | 0.0 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 87.1 | 12.9 | 0.0
| LWK | 32.7 | 47.3 | 20.0
| MEX | 73.7 | 24.6 | 1.8
| MKK | 48.1 | 44.2 | 7.7
| TSI | 84.3 | 14.7 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22414661
|Title=Investigating association of four gene regions (GABRB3, MAOB, PAH, and SLC6A4) with five symptoms in schizophrenia
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}